Artificial Intelligence and AI-Enabled Products

We help life sciences companies turn AI-enabled innovation into market-ready products and systems by pairing practical legal guidance with risk management, governance, and commercialization strategies across the product life cycle. Our attorneys advise on AI governance, model and vendor diligence, data rights and provenance, validation, human oversight, monitoring and change control, cybersecurity, IP and output rights, technology contracting, and allocation of AI-related risk. Our team also counsels clients on regulatory pathways for AI-enabled medical devices and clinical decision support tools, AI use in drug and biologic development and clinical research, and evolving federal, state, and international requirements. Working across regulatory, privacy, cybersecurity, IP, corporate, investigations, and disputes disciplines, we help clients advance AI-enabled innovation with practical governance, documentation, and life cycle controls.